4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-22-005327
Chief Financial Officer sold 1,347 shares at $4.33 ($5,834)
- Chief Financial Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PFREUNDSCHUH PETER P. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-14 | Exercise or conversion : show line 1 in the form | +15,000 | 15,745 | D | ||
| 2022-02-15 | Sale : show line 2 in the form | −1,347 | $4.33 | $5,834 | 14,398 | D |
| Open-market sales · 1,347 sh · avg $4.33 · $5,834 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2022-02-14 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −15,000 | 15,000 | 15,000 | D |
Loading xslF345X03/form4.xml…